Azaribine (Triazure) for severe psoriasis.
D000963:Antimetabolites / Q000009:adverse effects / Q000627:therapeutic use; D001380:Azauridine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010919:Placebos; D011247:Pregnancy; D011565:Psoriasis / Q000188:drug therapy*
D000963:Antimetabolites; D010919:Placebos; D001380:Azauridine; D008727:Methotrexate